Assessment and management of Raynaud's phenomenon

Abstract

Raynaud's phenomenon (RP) is commonly encountered in primary care and can either be a primary condition or occur secondary to a wide range of underlying medical conditions and drug therapies. This article discusses the assessment and treatment of RP and the GP's role in management.

Raynaud's phenomenon

“…The management of RP can be broadly considered under the two headings (which significantly overlap) of 'uncomplicated RP' and 'complicated RP', the latter of which involves progression to persistent tissue ischaemia (ie digital ulceration and/or gangrene; Fig 4). 44 Uncomplicated RP…”

Early diagnosis and management of systemic sclerosis

“…We have recently described in detail the assessment and management of Raynaud's phenomenon. 28 An approach to treatment of the condition is summarised in Table 4. Early diffuse cutaneous SSc is a management priority and often requires the introduction of immunosuppressive treatment (ie cyclophosphamide, methotrexate or mycophenolate mofetil).…”